![](/img/cover-not-exists.png)
Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment
BRAMLETTE, TRACY B., LAWSON, DAVID H., WASHINGTON, CARL V., VELEDAR, EMIR, JOHNS, BARRY R., BRISMAN, STACEY F., ABRAMOVA, LIANA, CHEN, SUEPHY C.Volume:
33
Language:
english
Journal:
Dermatologic Surgery
DOI:
10.1097/00042728-200701000-00002
Date:
January, 2007
File:
PDF, 182 KB
english, 2007